About Emil Pharmaceuticals
Emil Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1989. Pharmaceutical products are manufactured by Emil Pharmaceuticals for global markets. It operates on a Reseller / Distribution model. Emil Pharmaceuticals has raised $14.64 million across 1 funding round from investors including Somerset Indus Capital Partners. The company has 81 employees. Its chief executive, as recorded, is Shrirang Gadnis. Its Indian entity Emil Pharmaceutical Industries Private Limited reported revenue of ₹233 Cr. Emil Pharmaceuticals offers products and services including Pharmaceutical Products. Its focus areas include Pharmaceuticals and Generic Drugs.
Company details
Emil Pharmaceuticals is engaged in the manufacture of quality medicines for multinational companies such as Pfizer, Merck, and Novartis. Operations are conducted across two units with high-quality standards. Products are distributed to international markets including South and Central America, Africa, Southeast Asia, and CIS nations. Services include contract manufacturing, product development, and technology transfer. The company is focused on maintaining unmatched quality in the pharmaceutical sector.
- Headquarters Mumbai, India
- Employees 81
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website emilpharma.in
- Social LinkedIn
- Legal Name Emil Pharmaceutical Industries Private Limited
- Date of Incorporation 13 May, 1986
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹233 Cr
FY 2025 · +10% YoY
- Net Profit₹31.57 Cr
FY 2025 · 14% margin
- EBITDA₹52.93 Cr
FY 2025 · 23% margin
- Total Equity Funding$14.64M (USD)
in 1 rounds
- Latest Funding Round$14.64M (USD), Series B
Apr 2023
- Investors
- Employee Count81
Associated legal entities of Emil Pharmaceuticals
Emil Pharmaceuticals operates through Emil Pharmaceutical Industries Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Emil Pharmaceutical Industries Private Limited CIN U24230MH1986PTC039809 | Active | 13 May 1986 | Mumbai, Maharashtra | ₹233 Cr | 81 | 7 | View details |
Products & Services of Emil Pharmaceuticals
Emil Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products.
Medicines are manufactured for various multinational pharmaceutical companies.
Funding Insights of Emil Pharmaceuticals
Emil Pharmaceuticals has successfully raised a total of $14.64M through 1 strategic funding round. The most recent funding activity was a Series B round of $14.64 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.64M
- Total Rounds 1
- Last Round Series B — $14.64M
- First Round $14.64M
(Apr 2023)
- Investors Count 1
All 1 funding rounds of Emil Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2023 | $14.64M | Series B | – | – |
1 investors in total: 1 institutional.
Investors in Emil Pharmaceuticals
Emil Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Somerset Indus Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare investments focused on accessibility, affordability, and ESG integration in India. | 2011 | somersetinduscap.com | Mumbai, India |
Investor details for Emil Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Emil Pharmaceutical Industries Private Limited (Emil Pharmaceuticals)
Emil Pharmaceutical Industries Private Limited is the primary company behind Emil Pharmaceuticals. The board of Emil Pharmaceutical Industries Private Limited currently have 5 directors; the longest-serving is Tushar Anil Korday, appointed in 1986. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tushar Anil Korday DIN 00738316 | Director | 13 May 1986 | 40 yrs 5 mo | Emil Pharmaceutical Industries Private Limited |
| Manjiri Anil Devdhar DIN 02469390 | Director | 24 Feb 2004 | 22 yrs 8 mo | Emil Pharmaceutical Industries Private Limited |
| Sumegha Sanjiv Patange DIN 02005121 | Director | 24 Feb 2004 | 22 yrs 8 mo | Emil Pharmaceutical Industries Private Limited |
| Mayur Anand Sirdesai DIN 02830863 | Director | 17 Apr 2023 | 3 yrs 6 mo | Emil Pharmaceutical Industries Private Limited |
| Abhijit Rajendra Gole DIN 10625098 | Director | 19 Aug 2024 | 2 yrs 2 mo | Emil Pharmaceutical Industries Private Limited |
People of Emil Pharmaceuticals
3 people are tracked at Emil Pharmaceuticals (3 in leadership); the tracked headcount is 81.
| Name | Role | Group |
|---|---|---|
| Co-Owner & Director | Leadership | |
| Co-Owner | Leadership | |
Shrirang Gadnis | CEO | Leadership |
Complete people profiles for Emil Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Emil Pharmaceuticals
Figures of Emil Pharmaceutical Industries Private Limited, the primary company behind Emil Pharmaceuticals, for FY 2025. Revenue was ₹233 Cr (+10% year on year). Net profit was ₹31.57 Cr (14% margin). EBITDA was ₹52.93 Cr (23% margin). Revenue has grown at a compounded annual rate of +1% over three years and +7% over five years.
- ₹233 CrRevenue · FY 2025 · +10% YoY
- ₹31.57 CrNet profit · 14% margin
- ₹52.93 CrEBITDA · 23% margin
- ₹21.33 CrPaid-up capital
- 81Employees (provident fund records)
- +1%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Emil Pharmaceutical Industries Private Limited are on its company page.
Detailed financial statements for Emil Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Emil Pharmaceuticals
2 dated milestones of Emil Pharmaceuticals across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Emil Pharmaceuticals is founded.
- Funding First funding round of $14.6M.
Web traffic of Emil Pharmaceuticals
Websites that share an audience with Emil Pharmaceuticals (emilpharma.in).
Websites whose visitors overlap most with Emil Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| wellonapharma.com | 100% | 13.8K | #1,134,588 | View details |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Emil Pharmaceuticals (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 72.52 M | 1,115 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 4,050 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.44 B | 19,801 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Emil Pharmaceuticals
Emil Pharmaceuticals was founded in 1989 and raised its 1st funding round 34 years after it was founded.
Emil Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Shrirang Gadnis is the CEO of Emil Pharmaceuticals, as recorded in our data.
Emil Pharmaceuticals is a funded company, having raised a total of $14.64M across 1 funding round to date. The company's 1st funding round was a Series B of $14.64M, raised on Apr 2023.
Emil Pharmaceuticals has 81 employees.
The primary company behind Emil Pharmaceuticals, Emil Pharmaceutical Industries Private Limited, reported revenue of ₹233 Cr for FY 2025, up 10% year on year.
Emil Pharmaceuticals is engaged in the manufacture of quality medicines for multinational companies such as Pfizer, Merck, and Novartis. Operations are conducted across two units with high-quality standards. Products are distributed to international markets including South and Central America, Africa, Southeast Asia, and CIS nations. Services include contract manufacturing, product development, and technology transfer. The company is focused on maintaining unmatched quality in the pharmaceutical sector.
Emil Pharmaceuticals offers Pharmaceutical Products.
Emil Pharmaceuticals has 1 investor. Key investors include Somerset Indus Capital Partners.
Emil Pharmaceuticals operates through Emil Pharmaceutical Industries Private Limited.
The legal entities of Emil Pharmaceuticals currently have 7 directors, including Manjiri Anil Devdhar, Abhijit Rajendra Gole, Mayur Anand Sirdesai and others.